Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 60151-1-Ig - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#60151-1-Ig, RRID:AB_10641034
- Product name
- CUL4B antibody
- Antibody type
- Monoclonal
- Description
- KD/KO validated CUL4B antibody (Cat. #60151-1-Ig) is a mouse monoclonal antibody that shows reactivity with human, rat and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Rat
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 4E10B10
- Vial size
- 20ul, 150ul
Submitted references Insulin alleviates LPS-induced ARDS via inhibiting CUL4B-mediated proteasomal degradation and restoring expression level of Na,K-ATPase α1 subunit through elevating HCF-1.
NEDDylated Cullin 3 mediates the adaptive response to topoisomerase 1 inhibitors.
Cullin-4B promotes cell proliferation and invasion through inactivation of p53 signaling pathway in colorectal cancer.
miR‑381 and miR‑489 suppress cell proliferation and invasion by targeting CUL4B via the Wnt/β‑catenin pathway in gastric cancer.
Temporal Regulation of ESCO2 Degradation by the MCM Complex, the CUL4-DDB1-VPRBP Complex, and the Anaphase-Promoting Complex.
Huang XT, Zheng Y, Long G, Peng WT, Wan QQ
Biochemical and biophysical research communications 2022 Jun 30;611:60-67
Biochemical and biophysical research communications 2022 Jun 30;611:60-67
NEDDylated Cullin 3 mediates the adaptive response to topoisomerase 1 inhibitors.
Meroni A, Grosser J, Agashe S, Ramakrishnan N, Jackson J, Verma P, Baranello L, Vindigni A
Science advances 2022 Dec 9;8(49):eabq0648
Science advances 2022 Dec 9;8(49):eabq0648
Cullin-4B promotes cell proliferation and invasion through inactivation of p53 signaling pathway in colorectal cancer.
Zhong M, Zhou L, Zou J, He Y, Fang Z, Xiang X
Pathology, research and practice 2021 Aug;224:153520
Pathology, research and practice 2021 Aug;224:153520
miR‑381 and miR‑489 suppress cell proliferation and invasion by targeting CUL4B via the Wnt/β‑catenin pathway in gastric cancer.
Fang Z, Zhong M, Wang Y, Yuan X, Guo H, Yao Y, Feng M, Chen J, Xiong J, Xiang X
International journal of oncology 2019 Feb;54(2):733-743
International journal of oncology 2019 Feb;54(2):733-743
Temporal Regulation of ESCO2 Degradation by the MCM Complex, the CUL4-DDB1-VPRBP Complex, and the Anaphase-Promoting Complex.
Minamino M, Tei S, Negishi L, Kanemaki MT, Yoshimura A, Sutani T, Bando M, Shirahige K
Current biology : CB 2018 Aug 20;28(16):2665-2672.e5
Current biology : CB 2018 Aug 20;28(16):2665-2672.e5
No comments: Submit comment
No validations: Submit validation data